In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3923-3925

  Cirioni, Oscar ^a   Giacometti, Andrea ^a,b   Silvestri, Carmela ^a   Della Vittoria, Agnese ^a   Licci, Alberto ^a   Riva, Alessandra ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; BETA LACTAM ANTIBIOTIC; CATHELICIDIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; PROCOAGULANT; TRITRPTICIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DRUG POTENTIATION; IN VITRO STUDY; LIMULUS LYSATE TEST; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRONCHOALVEOLAR LAVAGE FLUID; DRUG COMBINATIONS; DRUG SYNERGISM; HUMANS; KINETICS; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; PSEUDOMONAS AERUGINOSA; WOUND INFECTION;

EID: 33750590541     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00652-06     Document Type: Article

References (23)

1. Cannon, M. 1987. A family of wound healers. Nature 328:478.
2. Carmeli, Y., N. Troillet, A. W. Karchmer, and M. H. Samore. 1999. Emergence of antibiotic-resistant Pseudomonas aeroginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob. Agents Chemother. 43:1379-1382.
3. Chamot, E., E. I. Boffi, E. Amari, P. Rohner, and C. Van Delden. 2003. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia. Antimicrob. Agents Chemother. 47:2756-2764.
4. Cohen, J., and J. S. McConnell. 1985. Antibiotic-induced endotoxin release. Lancet 2:1069-1070.
5. Darveu, R. P., M. D. Cunningham, C. L. Seachord, L. Cassiano-Clough, W. L. Cosand, J. Blake, and C. S. Watkins. 1991. β-Lactams antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob. Agents Chemother. 35:1153-1159.
6. Drabick, J. J., A. K. Bhattacharjee, D. L. Hoover, G. E. Siber, V. E. Morales, L. D. Young, S. L. Brownet, and A. S. Cross. 1998. Covalent polymyrin B conjugate with human immunoglobulin G as an antiendotoxin reagent. Antimicrob. Agents Chemother. 42:583-588.
7. Eliopoulos, G. M., and R. C. Moellering, Jr. 1996. Antimicrobial combinations, p. 330-393. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, Md.
8. Giacometti, A., O. Cirioni, R. Ghiselll, F. Mocchegiani, G. D'Amato, R. Circo, F. Orlando, B. Skerlavaj, C. Silvestri, V. Saba, M. Zanetti, and G. Scalise. 2004. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. Am. J. Resp. Crit. Care Med. 169:187-194.
9. Gough, M., R. E. W. Hancock, and N. M. Kelly. 1996. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64:4922-4927.
10. Hancock, R. E. W. 1997. Antibacterial peptides and the outer membranes of gram-negative bacilli. J. Med. Microbiol. 46:1-3.
11. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
12. Hancock, R. E. W., and M. G. Scott. 2000. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA 97:8856-8861.
13. Iwagaki, A., M. Porro, and M. Pollack. 2000. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14. Infect. Immun. 68:1655-1663.
14. McCafferty, D. G., P. Cudic, M. K. Yu, D. C. Behenna, and R. Kruger. 1999. Synergy and duality in peptide antibiotic mechanisms. Curr. Opin. Chem. Biol. 3:672-680.
15. Mouton, J. W., J. G. den Hollander, and A. M. Horrevorts. 1993. Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from cystic fibrosis patients. J. Antimicrob. Chemother. 31:919-926.
16. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Powers, J.-P. S., and R. E. W. Hancock. 2003. The relationship between peptide structure and antibacterial activity. Peptides 24:1681-1691.
18. Salay, L. C., J. Procopio, E. Oliveira, C. R. Nakaie, and S. Schreier. 2004. Ion channel-like activity of the antimicrobial peptide tritrpticin in planar lipid bilayers. FEBS Lett. 565:171-175.
19. Schibli, D. J., P. M. Hwang, and H. J. Vogel. 1999. Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold. Biochemistry 38:16749-16755.
20. Vaara, M., and M. Porro. 1996. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob. Agents Chemother. 40:1801-1805.
21. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
22. Yethou, J. A., and C. Whitfield. 2001. Lipopolysaccharide as a target for the development of novel therapeutics in gram-negative bacteria. Curr. Drug Targets Infect. Disord. 1:91-106.
23. Zanetti, M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39-48.